- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 16, 2025 | 164M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $25.09M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $37.02M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $44.6M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $94.4M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $96.71M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $134.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $150.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $103.77M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $121.45M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $255.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $268.06M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 153.08M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$16.15M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $139.78M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $144.14M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.07 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $11.81M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $6.4M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$11.27M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$21.91M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $12.16M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $10.03M |